Gracie Lieberman

Genentech, A Member of the Roche Group
Director Regulatory Policy
Gracie Lieberman is a Biostatistician with 30+ years of experience in oncology clinical trials. Gracie is a Director of Regulatory Policy at Genentech and focuses on utilization of RWE in regulatory decision-making. While working at Genentech for the past 22 years, Gracie has gained experience in all phases of drug development, including drug/diagnostic co-development. In 2011, she was a panelist, representing Genentech at the Annual Friends of Cancer Research Clinical Conference.